Drama therapy may be a unique approach to help patients with cancer express themselves and improve their emotional well-being. It can also help health care professionals improve their communication skills.
Fran Cartwright, PhD, RN-BC, AOCN, Senior Director of Nursing, Oncology Services and Medicine, NYU Langone Medical Center, discusses the importance of understanding the many facets of pain management.
Sometimes the most productive thing we can do is to stop.
At a median follow-up of 33.3 months, the median overall survival was not evaluable with cemiplimab, vs 20.7 months with chemotherapy alone, in this patient subset.
We need to either do away with the pink or change the color for inflammatory breast cancer (IBC), because it's not at all pink. It's black and blue, purple, and sometimes just plain red.
We were thrilled to cohost the Colorectal Cancer Survivor Panel Lunch & Learn at the recent OMG! Cancer Summit for Young Adults with our friends at Chris4Life.
Language barriers can mean patients put off preventive screenings, and even treatment, for fear of being misunderstood by their healthcare providers.
Newly standardized grading criteria will help to regulate the management of CAR T-cell therapy¬–related toxicities, like cytokine release syndrome (CRS) and immune effector cell-associated neurotoxicity syndrome (ICANS).
A phase 3 trial designed to evaluate eprenetapopt plus azacytidine (Vidaza) in patients with TP53-mutant positive myelodysplastic syndrome (MDS) completed full enrollment, according to Aprea Therapeutics, Inc.
Jan Lewin, PhD, section chief of Speech Pathology at the University of Texas MD Anderson Cancer Center, discusses head and neck lymphedema.
Nickhill Bhakta, MD, fellow at St. Jude Children’s Research Hospital, discusses some unanswered questions about late effects of adult survivors of childhood cancer.
Over the past several years, process improvements in the care of our oncology patients have been implemented that focus on the provision of safe and high quality clinical care and employee safety.
Some nurses share how they handle such remarks.
Claire Snyder, MHS, PhD, associate professor of medicine and oncology with a joint appointment in health policy and management at Johns Hopkins School of Medicine, discusses patient-reported outcome assessments and standardization of questionnaires.
Jyoti Patel, MD, of Northwestern University's Feinberg School of Medicine, talks about the subject of delaying whole brain radiation for brain metastases.
Ragini Kudchadkar, MD, explains what nurses should keep in mind when treating patients with basal cell carcinoma.
Rajni Kannan, BS, MS, RN, ANP-BC, discusses some risk factors for melanoma that may not be widely known.
A team of researchers at the University of Pittsburgh School of Nursing set out to better understand the interpersonal communication components of breast cancer navigation services.
Kathleen Wolf, RN, BSN, MBA, NEA-BC, discuss how nurses can tackle difficult conversations with patients.
Colleen OLeary from James Cancer Hospital Describes Chemotherapy Safety Standards
Beth Dailey, BSN, RN, OCN, HN-BC, from Cancer Treatment Centers of America at Eastern Regional Medical Center (ERMC), discusses how suggestions from nurses helped a merged clinic staff work smarter.
The future of treating patients with triple-negative breast cancer is bright, but more needs to be done to address mutations early on in the course of the disease.
In February 2002, I was diagnosed with stage I melanoma.
While COVID-19 continues to present much uncertainty for many people, those diagnosed with breast cancer are faced with unique challenges in navigating continued treatment.
Kaitlyn Francese, RN, a research nurse at NYU Langone Medical Center, discusses the difficulty she faces in getting patients on clinical trials to talk about their side effects.
The recent approval of ibrutinib plus obinutuzumab is a major advancement in the chronic lymphocytic leukemia space.
Dr. Alan Astrow discusses the importance of clinicians listening to all of a patient's concerns.
Clifford A. Hudis, MD, chief, Breast Cancer Medicine Service, Memorial Sloan Kettering Cancer Center, professor of medicine, Weill Cornell Medical College, discusses the challenges of understanding the link between obesity and cancer.
The September issue of Oncology Nursing News® offers a wealth of information on how oncology nurses can help their patients navigate psychosocial issues, from the moment of diagnosis and beyond.
Although excitement surrounds the constantly changing landscape of cancer care, we have much to learn to keep our practices current.